# Duloxetine Impact on Postoperative Pain Control and Outcomes

> **NCT05611749** · PHASE2 · TERMINATED · sponsor: **Scripps Health** · enrollment: 17 (actual)

## Conditions studied

- Acute Post-operative Pain
- Chronic Post Operative Pain
- Narcotic Use
- Opioid Use
- Opioid Addiction

## Interventions

- **DRUG:** Duloxetine 60 MG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05611749
- **Lead sponsor:** Scripps Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-30
- **Primary completion:** 2024-03-25
- **Final completion:** 2024-03-25
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Enrollment was extremely low and there were too many adverse events.
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05611749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05611749, "Duloxetine Impact on Postoperative Pain Control and Outcomes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05611749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*